Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel

BACKGROUND: Recent evidence suggests that in patients with immune thrombocytopenia (ITP) with a stable response on thrombopoietin receptor agonists, treatment may be tapered and/or discontinued. OBJECTIVES: The objective of this study was to provide a guide for tapering and discontinuation of TPO-RA...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Acta Haematol
Autors principals: Cooper, Nichola, Hill, Quentin A., Grainger, John, Westwood, John-Paul, Bradbury, Charlotte, Provan, Drew, Thachil, Jecko, Ramscar, Nicholas, Roy, Anuja
Format: Artigo
Idioma:Inglês
Publicat: S. Karger AG 2021
Matèries:
Original Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8315674/
https://ncbi.nlm.nih.gov/pubmed/33789275
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000510676
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars